Skip to content

Comparison of Femoral Nerve Catheter and Adductor Canal Block With Steroid Adjuvant in Total Knee Replacement (TKR)

Comparison of the Analgesic Efficacy of Continuous Femoral Nerve Block and Adductor Canal Block With Steroid Adjuvant in Patients Undergoing Total Knee Arthroplasty

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01973530
Enrollment
80
Registered
2013-10-31
Start date
2014-10-31
Completion date
2015-06-30
Last updated
2014-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

femoral nerve block, adductor canal block, steroid, total knee replacement

Brief summary

We hypothesize continuous adductor canal block with steroid adjuvant would offer no inferior analgesics and rehabilitation ability than continuous femoral nerve block for postoperative patients receiving total knee arthroplasty.

Detailed description

A total of 80 patients who will undergo total knee arthroplasty will be randomized into two groups: Treatment groups Treatment details Femoral Group (40 patients) Continuous femoral nerve block (bolus: 0.5% Ropivacaine 10-15 ml ; infusion of 0.15 % Ropivacaine 4-6ml/h) Adductor Group (40 patients) Adductor canal block with steroid adjuvant (bolus: 0.5% Ropivacaine 10-15ml; Dexamethasone 4mg) (Total 80 patients will be recruited) * All patients will receive single shot tibial nerve block with local anaesthetics (0.5% Ropivacaine 5-8ml) before surgery for analgesia of posterior knee. * All patients will receive the same preemptive and postoperative multimodal medications for perioperative analgesia. * All groups will receive standardized method of spinal anaesthesia and standardized method of intraoperative sedation for the surgery. * Intravenous patient controlled analgesia (PCA) with morphine will be given for 48h to patient as rescue analgesia.

Interventions

PROCEDUREadductor canal block

Continuous adductor canal block and single shot posterior tibial nerve block under ultrasound guidance and using nerve stimulating needle (bolus: 0.5% Ropivacaine 10-15ml with dexamethasone 4mg ;with single shot posterior tibial nerve block (8-10ml 0.5% ropivacaine)

PROCEDUREfemoral nerve block

Femoral nerve catheter inserted under ultrasound guidance using nerve stimulating needle administering ropivacaine bolus 10-15ml and infusing 0.2% ropivacaine at 4-6ml/h; plus a single shot posterior tibial nerve block under ultrasound guidance and use of nerve stimulating needle

Sponsors

Queen Elizabeth Hospital, Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of primary osteoarthritis * Scheduled for elective total knee arthroplasty * Signed written informed consent * Planned use of spinal anaesthesia * Cognitive sound to use assessment tools

Exclusion criteria

* Patients refusing to give consents * Scheduled for revision total knee replacement * Patient outside range of 30 to 80 yrs old * Non-chinese population * Cognitive impairment/ inability to use the outcome assessment tools * Contraindications to regional anesthesia * severe cardiovascular disease (unstable angina, second or third degree heart block) * pre-existing neurologic disease including psychiatric disorder * drug abuser * Pre-operative history of neurological abnormality in the ipsilateral leg e.g. history of stroke, neurogenic pain or previous nerve injury. * Allergy or contraindication to drugs used in this study: morphine, Non-steroidal anti-inflammatory drugs (NSAID) such as ketorolac , diclofenac, dihydrocodeine, local anaesthetics (lignocaine, ropivacaine, bupivacaine), epinephrine * Moderate or severe renal impairment (serum creatinine \> 160 micromol/l)

Design outcomes

Primary

MeasureTime frameDescription
PCA morphine or pain rescuer consumption at 24h and 48h postoperative24h and 48h postoperative
Postoperative pain score (visual analogue scale 0-10) at 6h,12h, 24h,48h, 72h after surgery6h,12h, 24h,48h, 72h after surgery
Quadriceps strength at 24h, 48h, 72h postoperative24h, 48h, 72h postoperativeusing dynamometer (measure in Newton/centimeter square)

Secondary

MeasureTime frame
postoperative nausea or vomiting0-72h
Patient satisfaction score (0-4)upon discharge
Haemastix on call and every 8 hours after surgery for postoperative 24hours for patientson call and every 8 hours after surgery for postoperative 24h
postoperative pruritis0-72h
Length of Stay in hospital 6. Length of Stay in hospital length of hospital stayupon discharge
Incidence of side effects and complications at postoperative day 0- 4 postoperativepostoperative period 0-96 hr postoperative

Countries

Hong Kong

Contacts

Primary ContactEric So, FHKCA FHKAM
sohke@ha.org.hk29588888

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026